Gender disparities in patients with melanoma: Breaking the glass ceiling

Journal of Clinical Oncology

Volumn 30, Issue 18, 2012, Pages 2177-2178

  Sondak, Vernon K ^a   Swetter, Susan M ^b   Berwick, Marianne A ^c  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER SURVIVAL; EDITORIAL; HUMAN; MELANOMA; PRIORITY JOURNAL; SEX DIFFERENCE;

FEMALE; HUMANS; MALE; MELANOMA; SEX CHARACTERISTICS; SKIN NEOPLASMS;

EID: 84864007908     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.41.3849     Document Type: Editorial

References (24)

1. Goss E, Lopez AM, Brown CL, et al: American Society of Clinical Oncology policy statement: Disparities in cancer care. J Clin Oncol 29:2881-2885, 2009
2. Moy B, Polite BN, Halpern MT, et al: American Society of Clinical Oncology policy statement: Opportunities in the Patient Protection and Affordable Care Act to reduce cancer care disparities. J Clin Oncol 29:3816-3824, 2011
3. Siegel R, Ward E, Brawley O, et al: Cancer Statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61:212-236, 2011
4. Joosse A, Collette S, Suciu S, et al: Superior outcome of women with stage I/II cutaneous melanoma: Pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials. J Clin Oncol 30:2240-2247, 2012
5. Gershenwald JE, Balch CM, Soong SJ, et al: Prognostic factors and natural history of melanoma, in Balch CM, Houghton AN, Sober AJ, et al (eds): Cutaneous Melanoma (ed 5). St Louis, MO, Quality Medical Publishing, 2009, pp 35-64
6. Thompson JF, Balch CM, Soong SJ, et al: Prognostic significance of mitotic rate in localized primary cutaneous melanoma: An analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol 29:2199-2205, 2011
7. Kölmel KF, Kulle B, Lippold A, et al: Survival probabilities and hazard functions of malignant melanoma in Germany 1972-1996, an analysis of 10,433 patients: Evolution of gender differences and malignancy. Eur J Cancer 38:1388-1394, 2002 (Pubitemid 34686851)
8. de Vries E, Nijsten TE, Visser O, et al: Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor type. Ann Oncol 19:583-589, 2008 (Pubitemid 351325683)
9. Lasithiotakis K, Leiter U, Meier F, et al: Age and gender are significant independent predictors of survival in primary cutaneous melanoma. Cancer 112:1795-1804, 2008 (Pubitemid 351536840)
10. Micheli A, Ciampichini R, Oberaigner W, et al: The advantage of women in cancer survival: An analysis of EUROCARE-4 data. Eur J Cancer 45:1017-1027, 2009
11. Joosse A, de Vries E, Eckel R, et al: Gender differences in melanoma survival: Female patients have a decreased risk of metastasis. J Invest Dermatol 131:719-726, 2011
12. Rampen FH: Sex differences in survival from cutaneous melanoma. Int J Dermatol 23:444-452, 1984
13. Schmidt AN, Nanney LB, Boyd AS, et al: Oestrogen receptor-beta expression in melanocytic lesions. Exp Dermatol 15:971-980, 2006 (Pubitemid 44696115)
14. Mori T, Martinez SR, O'Day SJ, et al: Estrogen receptor-alpha methylation predicts methylation progression. Cancer Res 66:6692-6698, 2006 (Pubitemid 44085626)
15. Hausauer AK, Swetter SM, Cockburn MG, et al: Increases in melanoma among adolescent girls and young women in California: Trends by socioeconomic status and UV radiation exposure. Arch Dermatol 147:783-789, 2011
16. Swetter SM, Layton CJ, Johnson TM, et al: Gender differences in melanoma awareness and detection practices between middle-aged and older men with melanoma and their female spouses. Arch Dermatol 145:488-490, 2009
17. Swetter SM, Johnson TM, Miller DR, et al: Melanoma in middle-aged and older men: A multi-institutional survey study of factors related to tumor thickness. Arch Dermatol 145:397-404, 2009
18. Lens MB, Rosdahl I, Ahlbom A, et al: Effect of pregnancy on survival in women with cutaneous malignant melanoma. J Clin Oncol 22:4369-4375, 2004 (Pubitemid 41185157)
19. Kvåle G, Heuch I, Nilssen S: Parity in relation to mortality and cancer incidence: A prospective study of Norwegian women. Int J Epidemiol 23:691-699, 1994 (Pubitemid 24260367)
20. Egan KM, Quinn JL, Gragoudas ES: Childbearing history associated with improved survival in choroidal melanoma. Arch Ophthalmol 117:939-942, 1999 (Pubitemid 29330782)
21. Rusthoven JJ, Quirt IC, Iscoe NA, et al: Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma: National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 14:2083-2090, 1996 (Pubitemid 26230110)
22. Falkson CI, Ibrahim J, Kirkwood JM, et al: Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: An Eastern Cooperative Oncology Group study. J Clin Oncol 16:1743-1751, 1998
23. Chapman PB, Einhorn LH, Meyers ML, et al: Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol 17:2745-2751, 1999 (Pubitemid 29415231)
24. Swetter SM, Pollitt RA, Johnson TM, et al: Behavioral determinants of successful early melanoma detection: Role of self and physician skin examination. Cancer [epub ahead of print on December 16, 2011]